dactinomycin has been researched along with deferoxamine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Casey, JL; Harford, JB; Horowitz, JA; Klausner, RD; Koeller, DM | 1 |
| Munro, H; Rogers, J | 1 |
| MacDonald, RA; MacSween, RN; Pechet, GS | 1 |
| Chu, LL; Fineberg, RA | 1 |
| Rittling, SR; Woodworth, RC | 1 |
| Henderson, BR; Kühn, LC | 1 |
| Farinelli, SE; Greene, LA; Park, DS; Stefanis, L; Yan, CY | 1 |
| Bonkovsky, HL; Cable, EE; Donohue, SE; Gildemeister, OS; Lambrecht, RW; Pepe, JA | 1 |
| Ashcroft, M; Taya, Y; Vousden, KH | 1 |
| Hirsch-Ernst, KI; Jungermann, K; Kahl, GF; Kietzmann, T; Ziemann, C | 1 |
| Balkwill, FR; Grimshaw, MJ | 1 |
| Dong, Z; Force, T; Nishiyama, J; Patel, Y; Saikumar, P; Semenza, GL; Venkatachalam, MA; Wang, J | 1 |
| Beaumont, C; Bourgeois, M; Martin, ME; Tchernitchko, D | 1 |
| Fujita, H; Furuyama, K; Hattori, T; Hida, W; Igarashi, K; Kitamuro, T; Nakayama, M; Ogawa, K; Shibahara, S; Shirato, K; Sun, J; Takahashi, K; Takeda, K; Udono-Fujimori, R | 1 |
| Becker, I; Giffhorn-Katz, S; Immenschuh, S; Katz, N; Ohlmann, A | 1 |
| Le, NT; Richardson, DR | 1 |
| Ann, DK; Bertolami, CN; Kelly, AP; Le, AD; Messadi, DV; Tuan, TL; Wu, Y; Zhang, Q | 1 |
1 review(s) available for dactinomycin and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for dactinomycin and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Translation and the stability of mRNAs encoding the transferrin receptor and c-fos.
Topics: Animals; Cell Line; Cycloheximide; Dactinomycin; Deferoxamine; Hemin; Humans; Mice; Plasmids; Protein Biosynthesis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Receptors, Transferrin; RNA, Messenger; Transfection | 1991 |
Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chelatable iron levels in rat hepatoma cells.
Topics: Animals; Cell Line; Dactinomycin; Deferoxamine; DNA; Ferritins; Heme; Iron; Liver Neoplasms, Experimental; Macromolecular Substances; Polyribosomes; Protein Biosynthesis; Rats; RNA, Messenger | 1987 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic Acid; Fatty Liver; Fluorides; Fructose; Glucose; Glutathione; Hemochromatosis; Inflammation; Iodoacetates; Iron; Lipotropic Agents; Liver Cirrhosis; Lung; Macrophages; Microscopy, Electron; Potassium Permanganate; Protein Biosynthesis; Puromycin; Rabbits; RNA; Saponins; Sucrose; Surface-Active Agents; Transferrin; Trypsin | 1969 |
On the mechanism of iron-induced synthesis of apoferritin in HeLa cells.
Topics: Antibodies; Carbon Isotopes; Cycloheximide; Dactinomycin; Deferoxamine; Ferritins; HeLa Cells; Humans; Iron; Iron Isotopes; Leucine; Phenanthrolines; Time Factors | 1969 |
The synthesis and turnover of ferritin in rat L-6 cells. Rates and response to iron, actinomycin D, and desferrioxamine.
Topics: Animals; Cell Line; Dactinomycin; Deferoxamine; Ferritins; Iron; Kinetics; Muscles; Rats | 1984 |
Differential modulation of the RNA-binding proteins IRP-1 and IRP-2 in response to iron. IRP-2 inactivation requires translation of another protein.
Topics: 3T3 Cells; Animals; Cycloheximide; Cytidine Triphosphate; Dactinomycin; Deferoxamine; Iron; Iron Regulatory Protein 1; Iron Regulatory Protein 2; Iron-Regulatory Proteins; Kinetics; L Cells; Melanoma, Experimental; Mercaptoethanol; Mice; Models, Structural; Protein Biosynthesis; RNA; RNA-Binding Proteins; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells.
Topics: Acetylcysteine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Aurintricarboxylic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Caspase 1; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; Enzyme Activation; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factors; PC12 Cells; Rats; RNA; Serpins; Viral Proteins | 1996 |
Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins.
Topics: 5-Aminolevulinate Synthetase; Allylisopropylacetamide; Animals; Cells, Cultured; Chick Embryo; Dactinomycin; Deferoxamine; Enzyme Inhibitors; Glutethimide; Heme; Heptanoates; Kinetics; Liver; Metalloporphyrins; Porphobilinogen Synthase; Regression Analysis; RNA, Messenger | 1996 |
Stress signals utilize multiple pathways to stabilize p53.
Topics: Blotting, Northern; Camptothecin; Cells, Cultured; Chelating Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; Deferoxamine; Down-Regulation; Enzyme Inhibitors; Fibroblasts; Humans; Immunoblotting; Microscopy, Fluorescence; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Serine; Stress, Physiological; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures.
Topics: Animals; Arteries; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Blotting, Northern; Cells, Cultured; Chelating Agents; Cobalt; Dactinomycin; Deferoxamine; Fluorescent Dyes; Heme; Hepatocytes; Immunoblotting; Male; Nucleic Acid Synthesis Inhibitors; Oxygen; Rats; Rats, Wistar; Rhodamine 123; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Veins | 2000 |
Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation--a potential mechanism.
Topics: Catalase; Cell Cycle Proteins; Cell Hypoxia; Chemotaxis; Dactinomycin; Deferoxamine; Dual Specificity Phosphatase 1; Humans; Immediate-Early Proteins; Inflammation; Macrophages; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monocytes; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |
Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Antimutagenic Agents; Apoptosis; Blotting, Northern; Cell Line; Cell Nucleus; Cells, Cultured; Chelating Agents; Cobalt; Dactinomycin; Deferoxamine; DNA-Binding Proteins; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Inhibitor of Apoptosis Proteins; Kidney; Mice; Models, Biological; Nuclear Proteins; Oxidation-Reduction; Oxygen; Protein Synthesis Inhibitors; Proteins; Rats; Stem Cells; Transcription Factors; Transcription, Genetic; Up-Regulation | 2001 |
Expression of the two mRNA isoforms of the iron transporter Nramp2/DMTI in mice and function of the iron responsive element.
Topics: Alternative Splicing; Animals; Cation Transport Proteins; Dactinomycin; Deferoxamine; Duodenum; Erythropoiesis; Gene Expression Regulation; Half-Life; HT29 Cells; Humans; Iron; Iron Chelating Agents; Iron-Binding Proteins; Kidney; Mice; Nucleic Acid Synthesis Inhibitors; Oxidants; Phenylhydrazines; Polymerase Chain Reaction; RNA, Messenger; Transfection | 2002 |
Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.
Topics: Animals; Basic-Leucine Zipper Transcription Factors; Blotting, Northern; Blotting, Western; Cattle; Cell Line; Cobalt; Dactinomycin; Deferoxamine; Dimerization; Fanconi Anemia Complementation Group Proteins; Gene Expression Regulation; Heme; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Hypoxia; Interferon-gamma; Leucine Zippers; Luciferases; Membrane Proteins; Models, Genetic; Oxidative Stress; Oxygen; Promoter Regions, Genetic; Rats; RNA, Messenger; Time Factors; Transcription Factors; Transfection; Tumor Cells, Cultured | 2003 |
Regulation of heme oxygenase-1 gene expression by anoxia and reoxygenation in primary rat hepatocyte cultures.
Topics: Allopurinol; Animals; Antioxidants; beta Carotene; Cell Hypoxia; Cells, Cultured; Cycloheximide; Dactinomycin; Deferoxamine; Free Radical Scavengers; Gene Expression Regulation, Enzymologic; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hepatocytes; HSP70 Heat-Shock Proteins; Iron Chelating Agents; Male; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion Injury | 2003 |
Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Topics: Cell Cycle; Cells, Cultured; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; DNA Damage; Gene Expression Regulation; Humans; Iron Chelating Agents; Isoniazid; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Biosynthesis; Receptors, Transferrin; RNA, Messenger; Tumor Suppressor Protein p53 | 2003 |
Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts.
Topics: Adult; Cell Hypoxia; Cells, Cultured; Cycloheximide; Dactinomycin; Deferoxamine; Female; Fibroblasts; Gene Expression Regulation; Half-Life; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Keloid; Male; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; RNA, Messenger; Transcription Factors | 2003 |